MedX Health Corp | March 03, 2022
MedX Health Corp.("MedX" or the "Company"), a global leader in teledermatology, is pleased to announce a Memorandum of Understanding (“MOU”) and the launch of a new commercialization pilot project with Health Partners (OH) Limited, a well-respected, privately-owned corporate health, treatment and primary care services company in the United Kingdom. Serving a broad client base comprising corporates, government agencies, insurers, health trusts, pension funds and individuals, Health Partners (“HP”) employs 700+ people with telehealth, mobile and on-site operations across the UK and the Republic of Ireland.
The pilot will span three to six months and involve an estimated 600 patients across two of HP’s sites. Upon the successful completion of the pilot, the MedX DermSecure® Screening Platform will be made available to Health Partners' two million-plus patients. The agreement is the latest initiative in MedX’s global commercialization strategy and follows pilots recently launched across the Europe and Middle East region.
"Health Partners’ Clinical Team constantly strives to identify leading technological innovations that offer the highest level of support to our two million-plus patients. MedX's leading skin assessment technology allows dermatologists to not only make more accurate diagnoses of pigmented lesions and moles, but to do that remotely and quickly. We are very proud to be partnering with MedX Health to bring this innovative and life-changing service to our clients.”
Health Partners Managing Director Andrew Noble
In addition to expanding its DermSecure® Screening Platform network globally, MedX has focused on building a presence in multiple market verticals such as pharmacies, medical clinics, building hubs, medical scanning clinics, mobile and remote medical practices, as well as esthetics and skincare clinics. The partnership with Health Partners represents MedX’s expansion into a new vertical; occupational health and wellbeing services.
MedX Managing Director, Europe, Middle East and Africa (EMEA), Naman Demaghlatrous, added, "MedX is pleased to have established a presence in the strategic occupational health vertical. Health Partners brings our technology to a population of more than two million workers across the United Kingdom, thus expanding our footprint in the EMEA region considerably. We continue to execute on our strategy to identify strategic partnerships in the region that will allow us to grow our business and save lives simultaneously.”
Health Partners will pilot MedX’s high-definition image-capture technology, SIAscopy®, and its secure, cloud-based patient management system, DermSecure®, which transmits and stores patient data throughout the assessment process. MedX's SIAscopy® is the only technology available that captures five high-resolution images of suspicious moles, lesions and skin conditions, including four spectrophotometric images taken 2mm below the skin's surface. This technology provides detailed patient scans, which a certified dermatologist can virtually assess within 72 hours.
"We are honoured to be working with Health Partners on this most important initiative. According to Health & Safety Executive-commissioned research, there are more than 3000 cases of skin cancer annually in the construction industryalone. We are delighted to be entering the occupational health services market with a leader in the industry," stated Mike Druhan, MedX President, Dermatology Services.
About Health Partners (OH) Ltd.
Health Partners, headquartered in Uckfield, East Sussex, United Kingdom, is a leading health and wellbeing company, providing a full range of corporate health, treatment and primary care services to corporates, government, insurers, health trusts, pension funds and families. We combine expert advice and clinical services with smart systems to deliver impact-driven health programmes, tailored to improve people’s wellbeing and performance.
Health Partners is founded on patient privacy and holds a significant number of accreditations, certifications and memberships, including ISO27001, CQC, SEQOHS and ISO9001. Health Partners offers its services across the United Kingdom and the Republic of Ireland, reaching two million plus people in organisations across several industries.
About MedX Health Corp.
MedX, headquartered in Ontario, Canada, is a leading medical device and software company focused on skin health with its SIAscopy® on DermSecure® telemedicine platform, utilizing its SIAscopy® technology. SIAscopy® is also imbedded in its products SIAMETRICS®, SIMSYS®, and MoleMate®, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS®, SIMSYS®, and MoleMate® include hand-held devices that use patented technology utilizing light and its remittance to view suspicious moles and lesions up to 2mm beneath in a pain-free, non-invasive manner. Its patented software then creates real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration and Conformité Européenne for use in Canada, the U.S., Australia, New Zealand, the European Union, Brazil and Turkey.
BAYADA | February 28, 2022
BAYADA Home Health Care, a leading not-for-profit home health care provider today launched its new, innovative suite of digital care transition and coordination solutions to assist hospitals and health plan point venture partners to better serve patients in their homes and communities. BAYADA has selected digital health care company, Dina, its current technology partner, as the platform to power these new, tech-enabled services.
The new digital tools leveraged by BAYADA will identify risks and track interventions as part of a new longitudinal care management program, bridging the acute and post-acute care worlds. By improving patient transitions from hospital to home-based care, BAYADA will help care teams stay connected, and create better, more cost-effective outcomes for patients and providers.
In a BAYADA trial including a cohort of patients with complex care needs, the approach has already created a significant impact. Patient hospitalization and emergency department visit rates were reduced by 42% and 30%, respectively, and the progression of patients moving from their homes into long-term, facility-based nursing care has also slowed.
“We’re excited to launch a highly scalable tech platform that offers seamless clinical integration, so we can coordinate multiple specialty services for seniors to help them stay safe and well cared for in their homes,” said David Baiada, CEO of BAYADA Home Health Care. “This will become increasingly important as care continues to move into homes, where people want to be.”
The COVID-19 pandemic has accelerated the adoption of home-based care, and most older Americans say they want to age in place.
“As organizations prepare to deliver care in a post-COVID world, it’s important that they not only invest in telehealth and remote patient monitoring capabilities, but also partner with forward-thinking homecare providers to better serve people in the home setting. We look forward to working with BAYADA to implement this new technology, and managing the care delivery logistics to make care-at-home safe, coordinated, reliable and excellent for patients and their families.”
Ashish V. Shah, CEO of Dina
The new tech-enabled services not only benefit patients, but major health systems as well, allowing BAYADA partners to:
Digitally transform post-acute care (PAC) network management and streamline the transitions of care experience for patients moving from hospital to home.
Create virtual care teams across disparate post-acute and community-based providers that connect physicians, nurses, care managers, patients, and their families with real-time, secure, mobile messaging, leading to fewer unplanned emergency room visits and readmissions.
Implement new, innovative care-at-home delivery models that keep the home as the primary destination for medically complex patients.
Address the health equity and social determinants of health (SDOH) needs for patients through data-driven partnerships with local, community-based service providers.
Better support the emerging needs of family caregivers as they work to formally collaborate with care teams to deliver exceptional outcomes at a lower cost.
BAYADA is one of the fastest-growing home health and hospice joint venture partners in the country and has joined forces with several major health systems and health plans in joint ventures and value-based care arrangements.
About BAYADA Home Health Care
BAYADA Home Health Care was founded by J. Mark Baiada in 1975 and provides nursing, rehabilitative, therapeutic, hospice and assistive care services to children, adults and seniors in the comfort of their homes. Headquartered in the Greater Philadelphia suburbs based in New Jersey, BAYADA employs more than 26,000 nurses, home health aides, therapists, medical social workers and other home health care professionals who serve their communities in 23 states from 347 locations, with locations in Canada, Germany, India, Ireland, New Zealand, South Korea and the United Kingdom.
In 2018, Baiada oversaw the company’s unprecedented transition to a not-for-profit organization to ensure BAYADA’s mission, purpose and business model would endure, and to help BAYADA realize its vision of helping millions of people worldwide experience a better quality of life at home; in early May 2019, the organization served its one millionth client.
Dina powers the future of home-based care. We are an AI-powered care-at-home platform and network that can activate and coordinate multiple home-based service providers, engage patients directly, and unlock timely home-based insights that increase healthy days at home. The platform creates a virtual experience for the entire healthcare team so they can communicate with each other--and help patients and families stay connected--even though they may not physically be under the same roof. Dina helps professional and family caregivers capture rich data from the home, using artificial intelligence to recommend evidence-based, non-medical interventions.
TytoCare | February 23, 2022
TytoCare, the global health care industry's first all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams, and Alice,Brazil'sfirst primary care-driven health insurance plan, have announced today a partnership. Alice is the first company inBrazilto integrate with TytoCare, offering its members an easy-to-use, portable examination kit to conduct virtual physical examinations anywhere, anytime, putting healthcare in the hands of consumers. TytoCare will be distributed exclusively inBrazilby Tuinda Care.
Alice, which inDecember 2021received the largest venture capital round ever reported inLatin Americaby a health tech company, began operations inJune 2020as an innovative tech-enabled health plan, built on the foundation of virtual-first, team-based primary care. Besides providing each of its members a 'Health Squad' ("Time de Saúde") – composed of a family doctor, a nurse, a nutritionist, and a physical trainer – the company also serves as a private health insurance provider with access to top-of-the-line hospitals, labs, and a network of medical specialists. Most hospitals in the network are contracted under a value-based healthcare (VBHC) payment model.
With the TytoCare partnership, Alice will enable seamless digital diagnostics for its members, while enabling physicians to offer clinic-quality virtual care. TytoCare is the only all-in-one telehealth solution enabling physicians to remotely connect with patients for clinic-quality physical examinations. The handheld examination kit enables users to perform comprehensive exams of the heart, skin, ears, throat, abdomen, and lungs, as well as measure heartrate and body temperature, which are key for treating many acute and chronic conditions. This allows healthcare providers to gain the vital clinical data they require to monitor, diagnose, and treat patients and avoid unnecessary in-person visits. All the data is stored in Alice's app and becomes available to all health professionals who care for the member, allowing for seamless care coordination.
"This data integration – the first of its kind inBrazil– enables the member's Health Squad to easily follow up on any chronic or acute condition, providing patients with long-term care while ensuring accuracy, speed, and convenience in both diagnoses and treatment plans. TytoCare also reduces costs and the need for travel to and from hospitals and clinics. In addition, it enables the health professional to share vital information with other physicians and specialists for a second opinion."
André Florence, CEO of Alice
TytoCare is easy to use and requires only an internet signal for members to conduct synchronous virtual consultations with their physician who can guide them through the exams and see the results in Alice's app. The physician can then better direct the member to the appropriate care pathway, either by referring them to an emergency room or by writing a digital prescription, when necessary. Currently, 15% of digital queries use TytoCare's support and with the integration, this number is expected to grow even further.
With TytoCare, Alice can offer better assistance to a member who has, for example, an earache in the middle of the night and opts to use 'Alice Now' ("Alice Agora") – an in-app, text-based virtual primary care service that supports audio and video and is available 24/7 for members who need immediate medical assistance. Within one hour, the member will receive the TytoCare device at home and the physician will guide them through a physical exam to see in real-time what is happening in the ear canal.
The TytoCare examination kit can be used to support the care of children and adults as well as for patients with more complex illnesses who need frequent monitoring. "Members with medical complexities use health services more frequently and can benefit from remote monitoring, reducing the frequency of in-person visits," saidAna Carolina Lucchese, Tuinda Care director. "Easier access to medical services can also prevent further complications and hospitalization."
TytoCare is a telehealth company using AI to transform primary care by putting health in the hands of consumers. TytoCare seamlessly connects people to clinicians to provide the best virtual home examination and diagnosis solutions.Its solutions are designed to enable a comprehensive medical exam from any location and include a hand-held, all-in-one tool for examining the heart, lungs, skin, ears, throat, abdomen, and body temperature; a complete telehealth platform for sharing exam data, conducting live video exams, and scheduling visits; a cloud-based data repository with analytics; and built-in guidance technology and machine learning algorithms to ensure accuracy and ease of use for patients and insights for healthcare providers. Co-founded byDedi GiladandOfer Tzadikin 2012, TytoCare has FDA and CE clearances and has partnered with over 170 major health systems, health plans, and strategic partners in the U.S.,Europe,Asia,Latin America, andIsrael.
Alice is currently considered the most promising health tech inLatin America. AsBrazil'sfirst primary care-driven health insurance plan, its mission is to make the world healthier. Launched inJune 2020, it already has nearly 7,000 members, more than 550 employees and has raised VC rounds at historically high levels for a health tech in the region. Founded by André Florence,Guilherme AzevedoandMatheus Moraes, the health tech has raised$174.8Mfrom the funds Allen & Company LLC, Canary, Endeavor Catalyst, Globo Ventures, G Squared, Kaszek, Maya Capital, StepStone Group, SoftBank Latin America Fund (SBLA) and ThornTree Capital Partners.
About Tuinda Care
Tuinda Care is a Healthtech startup focused on expanding access to high quality medical care inBrazilthrough telemedicine. It's the exclusive distributor of TytoCare technology inBrazil, with the purpose to connect clinicians and patients remotely, assuring medical excellence in every online visit. Tuinda Care is accelerated by Pequeno Príncipe Hospital and Sabará Pediatric Hospital, the two most prestigious pediatric hospitals inBrazil.